
Synkrino Biotherapeutics
Synkrino Biotherapeutics is a YC Summer 2018 (S18) company. Based in Oakland, CA, USA. Team of 2.
About Synkrino Biotherapeutics
Summary
Synkrino Biotherapeutics builds an AI-driven drug discovery system, SATIS, designed to identify therapeutic candidates without the biases that shape traditional discovery workflows. The platform targets the early-stage research bottleneck in biotech, replacing manual, hypothesis-constrained screening with automated, data-driven candidate identification.
From the Y Combinator listing
Synkrino's AI, SATIS is a powerful, unbiased discovery system for…
Facts
- Healthcare / Healthcare -> Drug Discovery and Delivery
- Oakland, CA, USA
- 2
- Active
- Early
Founders (2)
- David Ott
- Jason Barbour
Score every batch against your own thesis
GPAgent's sourcing agent reads every company in a batch, scores each one against your fund's thesis in a private workspace, and lines up the founders worth meeting before Demo Day. You decide who to contact. Your scores, notes, and pipeline never appear on these pages.
How Accelerator intelligence works